Revolutionizing Cardiac Mapping: J&J’s Biosense Webster Integrates AI into Carto 3 System

1. Johnson & Johnson's (J&J) subsidiary, Biosense Webster, has announced the integration of artificial intelligence (AI) into its Carto 3 System, a cutting-edge technology used for heart mapping.
2. The Carto 3 System is an advanced 3D mapping system that helps electrophysiologists navigate the heart and pinpoint the exact location of the abnormal heart tissue causing the arrhythmia.
3. The integration of AI into the Carto 3 System is expected to enhance its capabilities, potentially improving the accuracy and efficiency of cardiac mapping procedures.
4. This development marks a significant step forward in the field of electrophysiology, with the potential to revolutionize the way heart conditions are diagnosed and treated.
5. The AI-powered Carto 3 System could potentially reduce procedure times, improve patient outcomes, and lower healthcare costs.
6. The integration of AI into medical devices is a growing trend, reflecting the increasing role of technology in healthcare and medicine.
7. J&J's Biosense Webster is a global leader in the science of diagnosing and treating heart rhythm disorders, with a strong focus on innovation and improving patient care.